Insider · CIK 0001866167
Martin S A Beck
Files at UPH (UpHealth, Inc.). First filing -, latest -.
In brief
Martin S A Beck files SEC Form 4 as CEO, director and CFO at UPH (UpHealth, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Martin S A Beck has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | UPH UpHealth, Inc. | FTax withholding Common Stock | -932 | $0.70 | $652 | 36,160 | Jun 7, 2024 |
| Apr 11, 2024 | UPH UpHealth, Inc. | MOption exercise Common Stock | +12,340 | - | - | 48,500 | Jun 7, 2024 |
| Apr 11, 2024 | UPH UpHealth, Inc. | FTax withholding Common Stock | -3,658 | $1.04 | $3,804 | 44,842 | Jun 7, 2024 |
| May 22, 2024 | UPH UpHealth, Inc. | FTax withholding Common Stock | -699 | $0.48 | $336 | 44,143 | Jun 7, 2024 |
| Apr 11, 2024 | UPH UpHealth, Inc. | MOption exercise Performance Based Restricted Stock Unitderivative | -7,340 | $0.00 | $0 | 0 | Jun 7, 2024 |
| Apr 11, 2024 | UPH UpHealth, Inc. | MOption exercise Performance Based Restricted Stock Unitderivative | -5,000 | $0.00 | $0 | 4,350 | Jun 7, 2024 |
| Feb 13, 2024 | UPH UpHealth, Inc. | AGrant or award Employee stock option (right to buy)derivative | +1,300,000 | $0.00 | $0 | 1,300,000 | Feb 15, 2024 |
| Nov 27, 2023 | UPH UpHealth, Inc. | FTax withholding Common Stock | -701 | $0.61 | $428 | 37,092 | Nov 28, 2023 |
| Aug 22, 2023 | UPH UpHealth, Inc. | FTax withholding Common Stock | -701 | $1.33 | $932 | 37,793 | Oct 11, 2023 |
| Nov 1, 2022 | UPH UpHealth, Inc. | FTax withholding Common Stock | -4,468 | $0.53 | $2,346 | 426,271 | Nov 3, 2022 |
Questions about Martin S A Beck
Answered from the filings on this page, as of the latest one.
Is Martin S A Beck buying or selling?
Martin S A Beck has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Martin S A Beck's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Martin S A Beck has 0.
Where does Martin S A Beck file Form 4?
Martin S A Beck has filed Form 4 at UPH (UpHealth, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.